November 8, 2018
CTI Clinical Trial and Consulting Services (CTI), a multi-national, privately held, full-service contract research organization was honored by the Galien Foundation and Business France at the 2018 Prix Galien USA Awards Ceremony, which took place October 25, 2018 in New York City. CTI was recognized as winner of the Prix Galien – Medstartup Award, along with their partner Advicenne Pharma, in the category "Best Innovative Trial Design Leading to Quicker and Better Therapeutic Outcome". The Galien - Medstartup Award recognizes innovative and promising North America - French projects in clinical research based on market potential, business model, social benefits, financial forecast, innovation, and the strength of the partnership.
"We're honored to be recognized with our partners, Advicenne Pharma, for this prestigious award." remarks Timothy J. Schroeder, Founder and CEO. "The work we're doing with Advicenne on this innovative trial in rare disease renal patients is a true joint effort that we hope leads to better outcomes for these patients that currently have limited options for treatment. We appreciate the Galien Foundation and Business France recognizing this project and bringing attention to this research, as well as all the others nominated."
The Prix Galien USA Awards Ceremony launched in 2007, first honoring unique medical products, later devices, and finally, individuals who have impacted patient care through innovation. The Awards Ceremony and dinner is held annually at the New York City Museum of Natural History. Co-founded by the Galien Foundation and Business France, the Prix Galien – Medstartup encourages and rewards the most promising startups in healthcare formed through international partnerships. The program brings together innovators and stakeholders to facilitate rapid adoption and encourages the diffusion of new technologies to improve the state of human health.